Changeflow GovPing Healthcare & Life Sciences Substituted Indazoles for Treating Animal Aller...
Routine Notice Added Final

Substituted Indazoles for Treating Animal Allergic Inflammatory Diseases

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO has published a patent application detailing the use of substituted indazoles for the treatment and prevention of allergic and inflammatory diseases in animals. The application, filed on October 9, 2025, outlines specific compounds and their potential applications in veterinary medicine.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a USPTO patent application (US20260085057A1) for substituted indazoles intended for treating and preventing allergic and/or inflammatory diseases in animals. The application specifies uses for conditions such as atopic dermatitis, flea allergy dermatitis, inflammatory bowel disease, osteoarthritis, and respiratory diseases in animals.

While this is a patent application and not a regulatory rule, it signals potential future developments in veterinary pharmaceuticals. Companies involved in animal health or pharmaceutical research may find this disclosure relevant for competitive intelligence and potential licensing opportunities. No immediate compliance actions are required for regulated entities based on this filing.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS

Application US20260085057A1 Kind: A1 Mar 26, 2026

Inventors

Gerald BEDDIES, Adrian FOSTER, Ulrich BOTHE, Nicole SCHMIDT, Ulf BOEMER, Reinhard NUBBEMEYER, Maria De Lourdes MOTTIER

Abstract

The present application relates to the use of substituted indazoles for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially for treatment and/or prophylaxis of atopic dermatitis, Flea Allergy Dermatitis, inflammatory bowel disease, osteoarthritis and inflammatory pain, non-infectious recurrent airway disease, insect hypersensitivity, asthma, respiratory disease, mastitis and endometritis in animals.

CPC Classifications

C07D 401/12 C07D 405/14

Filing Date

2025-10-09

Application No.

19353722

View original document →

Named provisions

Abstract

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260085057A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Veterinary Medicine
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Animal Health Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!